Quinidine Sulfate Market Seen Soaring 7.1% Growth to Reach USD 500 Million by 2030, Projects Univdatos Market Insights

• Vikas Kumar
• November 15, 2023
• HEALTHCARE, NEWS
• Quinidine Sulfate, Quinidine Sulfate Market, Quinidine Sulfate Market analysis, Quinidine Sulfate Market forecast, Quinidine Sulfate Market growth, Quinidine Sulfate Market share, Quinidine Sulfate Market trends
• 0 Comments

Key Highlights of the Report:

• Growing demand in the healthcare sector: The quinidine sulfate market is experiencing significant growth due to increasing demand in the healthcare sector, driven by growing concerns over widespread cases of malaria.
• Rise in pharmaceutical market: There has been growing demand for pharmaceuticals owing to increased incidences of bad lifestyle, and unhealthy food consumption.
• FDA-approved combinations: The FDA-approved usage of quinidine sulfate for treating multiple indications combined with other drugs for medical conditions.

According to a new report by Univdatos Market Insights, Quinidine Sulfate Market is expected to reach USD 500 Million in 2030 by growing at a CAGR of 7.1%. Quinidine, sold under the brand name Nuedexta, is an antimalarial agent and an antiarrhythmic with the chemical constitution of cinchona alkaloid. Quinidine blocks the sodium and potential currents and prolongs cellular action potential. Quinidine sulfate is generally used to treat malaria, arrhythmia, sinus rhythm, and others. While considering the mode of administration, the oral type held the maximum share while comparing other dosage types of quinidine sulfate owing to its ease of consumption and higher effectiveness. Several factors are contributing to the growth of quinidine sulfate including the surge in cases of malaria, the surge in awareness programs regarding heart diseases, and rising investments in healthcare departments are driving the growth of quinidine sulfate. For instance, in September 2021, U.S.-based Azurity Pharmaceuticals Inc. acquired Arbor Pharmaceuticals LLC for, high-value goods to address the requirements of patients with chronic illnesses.

Access Sample PDF Here – https://univdatos.com/get-a-free-sample-form-php/?product_id=49158

The report suggests that the Rising Research on Cardiovascular Diseases is one of the major factors driving the growth of the quinidine sulfate market during the forthcoming years. Quinidine Sulfate has gained support in terms of research and development in pharmaceutical industries. Money is an essential factor for gaining prominence in the market and cardiovascular disease research is attracting a huge load of money investments. This expenditure is driving the market for the development of new technological advancements in quinidine sulfate. In recent years, there has been an increasing number of launches, FDA approvals, and an increasing number of technological advancements focused on cardiovascular diseases. For instance, in December 2021, AstraZeneca proposed the idea of designing oral biologics using transient permeation enhancers which are expected to increase the half-life and allow improved stability against intestinal enzymes. It also provides hope for patients to get better care and support through quinidine sulfate, also it can serve as a doorway of opportunities for offering better treatment options in the future.

Few FDA-approved Drug Combinations with Quinidine:

• Abacavir: Abacavir may decrease the excretion rate of Quinidine which could result in a higher serum level.
• Abciximab: The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine.
• Abemaciclib: The serum concentration of Abemaciclib can be increased when it is combined with Quinidine.
• Acalabrutinib: The metabolism of Acalabrutinib can be decreased when combined with Quinidine.
• Acamprosate: The excretion of Acamprosate can be decreased when combined with Quinidine.
• Acebutolol: Quinidine may increase the arrhythmogenic activities of Acebutolol.
• Acemetacin: Acemetacin may decrease the excretion rate of Quinidine which could result in a higher serum level.
• Acenocoumarol: The serum concentration of Acenocoumarol can be increased when it is combined with Quinidine.

Conclusion

The global quinidine sulfate market is a rapidly growing field, with advancements in technology leading to improved outcomes for patients with malaria, cardiovascular disorders, and other ailments. The global quinidine sulfate market is expected to continue to grow in the coming years, as new technologies are developed. Overall, the global quinidine sulfate market represents a significant opportunity for pharmaceutical industries, which are making strategic alliances to design an effective drug for chronic disease treatment. With continued research and development, it is likely that even more treatments will become available in the future, leading to improved outcomes for patients through quinidine sulfate.

Key Offerings of the Report

Market Size, Trends, & Forecast by Revenue | 2023−2030.

Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

Market Segmentation – A detailed analysis by Mode of Administration, Application, and Region

Competitive Landscape – Top Key Vendors and Other Prominent Vendors